scholarly journals A left ventricular end-diastolic dimension less than 6.0 cm is associated with mortality after implantation of an axial-flow pump

2019 ◽  
Vol 157 (6) ◽  
pp. 2302-2310 ◽  
Author(s):  
Masashi Kawabori ◽  
Chitaru Kurihara ◽  
Ryan Conyer ◽  
Tadahisa Sugiura ◽  
Andre C. Critsinelis ◽  
...  
ASAIO Journal ◽  
2002 ◽  
Vol 48 (2) ◽  
pp. 152 ◽  
Author(s):  
Michel Carrier ◽  
Andre Garon ◽  
Louis Conrad Pelletier

2008 ◽  
Vol 20 (2) ◽  
pp. 124-127 ◽  
Author(s):  
Hiroaki Konishi ◽  
James F. Antaki ◽  
Philip Litwak ◽  
Marina Kameneva ◽  
Kenji Yamazaki ◽  
...  

2005 ◽  
Vol 18 (12) ◽  
pp. 1422.e7-1422.e13 ◽  
Author(s):  
Emanuele Catena ◽  
Filippo Milazzo ◽  
Emanuela Montorsi ◽  
Giuseppe Bruschi ◽  
Aldo Cannata ◽  
...  

2020 ◽  
Vol 9 (12) ◽  
pp. 4130
Author(s):  
Jérôme Fagot ◽  
Frédéric Bouisset ◽  
Laurent Bonello ◽  
Caroline Biendel ◽  
Thibaut Lhermusier ◽  
...  

We investigated prognostic factors associated with refractory left ventricle (LV) failure leading to LV assist device (LVAD), heart transplant or death in patients on an axial flow pump support for cardiogenic shock (CS). Sixty-two CS patients with an Impella® CP or 5.0 implant were retrospectively enrolled, and clinical, biological, echocardiographic, coronarographic and management data were collected. They were compared according to the 30-day outcome. Patients were mainly male (n = 55, 89%), 58 ± 11 years old and most had no history of heart failure or coronary artery disease (70%). The main etiology of CS was acute coronary syndrome (n = 57, 92%). They presented with severe LV failure (LV ejection fraction (LVEF) 22 ± 9%), organ malperfusion (lactate 3.1 ± 2.1 mmol/L), and frequent use of inotropes, vasopressors, and mechanical ventilation (59, 66 and 30%, respectively). At 24 h, non-recovery was associated with higher total bilirubin (odds ratios (OR) 1.07 (1.00–1.14); p = 0.039), lower LVEF (OR 0.89 (0.81–0.96); p = 0.006) and the number of administrated amines (OR 4.31 (1.30–14.30); p = 0.016). Early evaluation in patients with CS with an axial flow pump implant may enable the identification of factors associated with an unlikely recovery and would call for early screening for LVAD or heart transplant.


Sign in / Sign up

Export Citation Format

Share Document